Portable Oxygen Concentrators Market to Observe Strong Development by 2026

According to a latest report published by Future Market Insights titled “Portable Oxygen Concentrators Market: Global Industry Analysis and Opportunity Assessment, 2016–2026,” the global portable oxygen concentrators market is anticipated to register a CAGR of 7.8% between 2016 and 2026 in terms of value. 

Portable oxygen concentrators supply oxygen to patients suffering from respiratory diseases such as chronic obstructive pulmonary diseases. The concentrator separates nitrogen and oxygen from air in the environment and then supplies 95% pure oxygen to patients. POCs are easy to carry as they are smaller in size compared to stationary concentrators. Moreover, POCs are of great use to mountaineers and travellers in places where oxygen is inadequate. 

According to Future Market Insights, the global portable oxygen concentrators market is likely to witness substantial growth owing to increasing prevalence of chronic obstructive pulmonary diseases, growing consumer awareness for oxygen therapy devices, and a changing consumer lifestyle. Further, adoption of new technologies in medical devices, increasing government expenditure towards healthcare and medical devices development and production, and a rise in investment by companies manufacturing homecare products is likely to boost the growth of the global portable oxygen concentrators market during the forecast period (2016 – 2026). However, high product costs and stringent FDA regulations pertaining to medical devices are some of the factors likely to restrain the growth of the global portable oxygen concentrators market during the forecast period. 

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1061

Segmentation highlights

The global portable oxygen concentrators market has been segmented on the basis of Product into Continuous Flow Portable Oxygen Concentrator and Pulse Flow Portable Oxygen Concentrator; and on the basis of End User into Hospitals, Homecare, Ambulatory Surgical Centres, and Travel Agents.

• The Pulse Flow Portable Oxygen Concentrator product segment is projected to be valued at US$ 1890.3 Mn by 2026, registering a CAGR of 9.0% over the forecast period
• The Homecare end user segment is projected to be valued at US$ 1820.5 Mn by 2026 and is likely to witness a CAGR of 9.0% over the forecast period 

Regional market projections

The global portable oxygen concentrators market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. Growing geriatric population consequently increasing the requirement for homecare settings particularly in high income countries with increasing number of patients suffering from chronic obstructive pulmonary diseases is expected to result in significant growth of the North America portable oxygen concentrators market. The North America region is expected to report incremental opportunity of US$ 781.7 Mn between 2016 and 2026. Evolution of health insurance system is expected to contribute largely to the revenue generation potential and attractiveness of the Eastern Europe portable oxygen concentrators market. Rising adoption of portable oxygen concentrators in chronic obstructive pulmonary diseases patients for better care is expected to fuel revenue growth in the Japan portable oxygen concentrators market over the forecast period. High product cost of portable oxygen concentrators is expected to hamper sustainable adoption in the APEJ region. Lack of product awareness is expected to hamper market growth in the APEJ and MEA regions.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1061

Vendor insights

The report profiles some of the top companies operating in the global portable oxygen concentrators market such as Koninklijke Philips N.V., Inogen Inc., Chart Industries Inc., Resmed Inc., Invacare Corporation, Drive DeVilbiss Healthcare, Precision Medical Inc., Besco Medical Co. Ltd., Oxus America, Inc. (Oxus), Foshan Keyhub Electronic Industries Co. Ltd., O2 Concepts LLC, and GCE Group. Key strategies adopted by leading market players in the global portable oxygen concentrators market include product approvals and commercialisation, efficient entry into markets in emerging countries, and adoption of latest innovative technologies in healthcare, thus strengthening regional proficiency and addressing customer needs effectively. New product launches, product innovation, and geographical expansion are anticipated to form the core of these strategies during the forecast period.

Orthopaedic Prosthetics Market Will Generate New Growth Opportunities by 2028

While the use of 3D printing technology in healthcare sector aims to make healthcare as affordable as possible for everyone, orthopedics and prosthetics have gained the spotlight among 3D printing device manufacturers. In addition to wide availability of technically advanced orthopedic prosthetics, escalating demand for custom-made orthopedic prosthetics is likely to push the growth of the global orthopedic prosthetics market in the next decade.

Although associated risks and technical complications are still creating a major roadblock in widespread adoption of orthopedic prosthetics, a new set of technological innovations holds the promise to positively influence the sales of orthopedic prosthetics in near future. One of the innovations includes 3D printed orthopedic prosthetics, which has been observed to impact the scenario for customized orthopedic prosthetic devices.

3D Printing Becomes Fast Track Technology for Tailor-made Orthopedic Prosthetics & Supports

Three-dimensional printing is identified to be a rapid way for manufacturing bespoke orthopedic supports and prosthetics, which efficiently compensate for a deformity, predominantly caused due to a lost limb or paralysis. 3D printed test sockets have already been registering a consistently positive feedback from patients, owing to the comfort, convenience, and well-fitting design. Handicap International (Humanity & Inclusion), a charity, has initiated the use of 3 dimensional printing technology in the making of customized orthopedic prosthetic devices. This technology aids in faster production of devices, and thus offers wider outreach.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1443

Already having launched in developed economies, followed by significantly growing adoption, these bespoke device manufacturing technology is still in its nascent stage within developing economies, prominently due to supply-demand imbalance. A recent survey points out that a maximum of 5% of the total 15% patient population within emerging economies, who need a prosthetic support, brace, or limb, are currently able to get one. The charity is constantly emphasizing R&D along with clinical trials of 3D printed orthopedic prosthetics within developing countries with poor infrastructural settings. The NGO’s current program, which is gaining enormous funds, has also offered free made-to-measure 3D orthopedic prosthetic devices to hundreds of patients.

While 3D printing is being perceived as a revolutionary method for orthopedic doctors located in remote areas or conflict zones, as the scanner involved in this process is compact, portable, and convenient to use. However, high price point associated with the manufacturing of these orthopedic prosthetic devices will continue to limit adoption over the next few years.

Reimbursement Scenario Plays a Crucial Role in Pushing Adoption

Rising instances of accidental injuries and growing prevalence of arthritis, have been the key factors fueling the demand for orthopedic prosthetic devices, over the years. Increasing adoption of advanced technology and customized implantable products will also push the market for orthopedic prosthetics in next few years. Favorable reimbursement policies for orthopedic prosthetics will continue to keep the market up in developed economies. However, the market for orthopedic prosthetics within emerging economies is anticipated to thrive at a relatively moderate pace, owing to inadequate reimbursement scenario and lower awareness about the advances and availability of orthopedic prosthetic devices.

As indicated by a recently released market research intelligence report by Future Market Insights (FMI), the global market value for orthopedic prosthetics will possibly cross the mark of US$ 3 billion by the end of 2028. During the projection period 2018-2028, the global orthopedic prosthetics market is expected to witness progressive expansion at a CAGR of 5.1%.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1443

The prices of 3D printed orthopedic prosthetics will possibly witness a dramatic fall in near future, provided that the trials go well and prove to be successful among a considerably large patient population, already using 3D orthopedic prosthetics. It remains to be seen yet, to what extent the innovation in 3D printing will impact the existing options available in orthopedic prosthetic devices. Will growing popularity and adoption of 3D printing technology among orthopedic prosthetic device manufacturers set the global orthopedic prosthetics market at a higher momentum?

North America and Europe Dermal Filler Market Will Generate New Growth Opportunities by 2026

Future Market Insights (FMI) delivers key insights on the North America and Europe dermal filler market in its latest report, titled “North America and Europe Dermal Filler Market: Industry Analysis and Opportunity Assessment, 2016-2026.” In terms of revenue, the North America and Europe dermal filler market is projected to register a promising CAGR of 6.4% over the forecast period, owing to numerous factors, about which FMI offers thorough insights and forecasts in this report.

The factors powering demand for dermal fillers are aging population, increasing expenditure on aesthetics and beauty procedures, introduction of new areas of application such as HIV induced facial lipoatrophy, enhancement of dorsal area of hand and rising demand for non-invasive aesthetic procedures over surgical aesthetic procedures.

However, higher cost associated with the dermal filler procedure, patch up or reinjection needed for achieving the desired facial rejuvenation for absorbable dermal fillers and some post procedure complications associated with dermal fillers like bruising, redness and granulation are some factors expected to hamper growth of the North America and Europe dermal filler market over the forecast period.

Key trend defining the market is the prominent players acquiring smaller players in aesthetics product domain, consequently increasing their infrastructure along with expanding their product portfolio. Also, big players are partnering with local and smaller companies for distribution of their products on a regional level in pursuance of capturing the market share. Furthermore, dermal filler manufacturers are also increasingly concentrating on end user engagement to retain and expand their market share. 

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-na-2105

Segmentation highlights

• The market is segmented based on product type, filler material, distribution channel and region. Based on product type, the market is segmented into absorbable fillers and non-absorbable fillers.
• Among the product type segment, absorbable product type segment is expected to exhibit the highest revenue growth over the forecast period. The absorbable product type segment is expected to register a significant CAGR of 6.5% during the forecast period in terms of value. The non-absorbable product segment is projected to register CAGR of 4.5% over the forecast period.  
• To provide in-depth insights on the pattern of demand for dermal fillers, the market is segmented into different type filler material such as hyaluronic acid (HA), poly-L-lactic acid (PLLA), calcium hydroxylapatite (CaHA), polymethylmethacrylate (PMMA) and collagen. The hyaluronic acid material segment is projected to register a significant CAGR of 6.7% over the forecast period in terms of value.
• The market has also been segmented by distribution channel into retail pharmacies and drug stores, clinics and hospital pharmacies and online sales segments. Clinics and hospital pharmacy distribution segment is expected to be the highest in terms of revenue over the forecast period, with the segment registering a CAGR of 7.8%.
• Retail pharmacies and drug stores are projected to witness a CAGR of 6.8% over the forecast period. One of the major growth supporter for the dermal filler market is the office based procedure and small time required for procedure (30 to 60 minutes). 

Regional market projections

This report assesses trends in driving growth of each segment on the collective as well as regional level and offers potential takeaways that could prove substantially useful to dermal filler manufacturers looking forward to enter the market. North America market is expected to dominate the dermal filler market, accounting for maximum revenue share by 2016 end. Western Europe market is expected to account for approximately 28.5% revenue share of the North America and Europe dermal filler market by 2016 end. Among the emerging markets, Germany is projected to exhibit a significant CAGR of 7.2% over the forecast period, followed by France, due to rising demand for non-invasive aesthetics procedures and increasing expenditure on aesthetic procedures. 

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-na-2105

Vendor insights

Some of the key players in the North America and Europe dermal filler market include Allergan plc., Galderma Pharma S.A., Sinclair Pharma S.A., Anika Therapeutics Inc., Suneva Medical Inc. and Merz Pharma GmbH and Co. KGaA. In this report, FMI has discussed individual strategies followed by these companies in terms of enhancing their product portfolio, creating new marketing techniques, mergers and acquisitions. The ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and company share collectively.

Teleradiology Services Market to Witness Comprehensive Growth by 2026

Future Market Insights delivers key insights on the global teleradiology services market in a new publication titled “Teleradiology Services Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. Teleradiology is the practice of interpretation and analysis of medical images by a radiologist who is not present at the site where the images are generated. This service is utilised by hospitals, emergency care centres, telemedicine companies, and other clinics. Teleradiology services enable radiologists to use online services in order to improve patient care and treatment without the need to be physically present on site. In terms of revenue, the global teleradiology services market is projected to register a healthy CAGR of 21.0% over the forecast period (2016 – 2026) and increase 6.7x in terms of revenue between 2016 and 2026.

The global teleradiology services market is anticipated to project exponential growth over the next 10 years owing to increasing incidences of chronic diseases such as cancer, tumours, and orthopaedic diseases; increasing geriatric population; and excessive hospitalisations and increasing admittance in ambulatory surgical centres and clinics. Increasing consumer awareness regarding teleradiology and easy accessibility to the technology is another key factor likely to drive the global demand for teleradiology services. However, high cost of technology and services, image transmission issues, dearth of trained radiologists and technicians, and a low awareness in emerging economies is likely to pose major challenges for the growth of the global teleradiology services market. Ongoing trends for teleradiology services driving the global market include service offerings with the latest IT infrastructure including artificial intelligence and algorithms, cloud with low maintenance, and image backup storage.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-2100

Segmentation highlights

The global teleradiology services market is segmented on the basis of Process Type (Certified Reporting Services Process, Preliminary Reporting); Service Type (Emergency Nighthawk, Day Time Coverage, Subspecialty Reading, Second Opinion, Clinical Trails); Modality (X-Ray Scans, Computerised Tomography (CT) Scans, MRI Scans, Ultrasound Scans, Nuclear Scans, Cardiac Echo, Mammography, Electromammography); and End User (Hospital Pharmacies, Clinics, Ambulatory Surgical Centres, Radiology Centres).

• Certified Reporting Services Process segment is estimated to account for 62.9% revenue share of the global teleradiology services market by 2016 end
• Emergency Nighthawk service type segment accounted for 31.6% value share in 2015 and is anticipated to dominate the global teleradiology services market throughout the forecast period
• Computerised Tomography (CT) Scans modality segment is anticipated to register a CAGR of 23.6% between 2016 and 2026
• Hospital Pharmacies end user segment is estimated to account for 39.9% revenue share of the global teleradiology services market by 2016 end

Regional market projections

The global teleradiology services market is segmented on the basis of region into U.S. and OUS (International) (Latin America, EU5, Rest of Europe, Japan, Asia Pacific Excluding Japan, Rest of the World). The U.S. regional market dominated the global teleradiology services market in revenue terms in 2015 and is projected to account for 41.2% market value share by 2026 end. The EU5 region is expected to be the second most lucrative segment in the global teleradiology services market with a market attractiveness index of 1.3 during the forecast period.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-2100

Vendor insights

The report profiles some of the leading players operating in the global teleradiology services market. Top companies featured in the report include Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings Inc., Vital Radiology Services, Teleradiology Providers, Telemedicine Clinic, TeleDiagnosys Services Pvt. Ltd, Imaging Advantage, Foundation Radiology Group, Direct Radiology, Imaging On Call LLC, ONRAD Inc., Rays (Envision Healthcare Company), StatRad LLC, ARIS Radiology, NightShift Radiology, Mednax Inc., Alta Vista TeleRadiology, and Quality Nighthawk. These established players are focussed on strategic moves such as new product launches, increasing their distribution channels, and getting into partnerships and agreements with hospitals and specialty clinics to increase the brand awareness of their product.

Central Venous Catheter Market Will Generate New Growth Opportunities by 2026

Need for minimal invasive surgeries have been increasing since few years as it reduces the possibilities of postoperative complications. This has led to increasing production sales of central venous catheters across the global market. Rapid increase in the number of cancer patients are likely to drive the production sales of central venous catheters for the purpose of completing chemo processes, which the treatment for cancer much easier. Geriatric population are likely to experience more chronic health conditions, especially chronic kidney diseases, thereby fuelling demand and supply of CVCs. Apart from this, increasing rate of hospitalization and drug administration in the outpatient settings where the patient is in need of IV therapy, stimulates the growth of central venous catheter market.

A Sample of this Report is Available upon Request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-949 

The National Center for Biotechnology Information is of the point of view that data assessment strategies and quality indicators for the purpose of preventing bloodstream infections with central venous catheter has been developed. Launch of sterile and disposable catheters has unlocked significant growth opportunities for market for central venous catheters as it helps in preventing infections while using catheter Leading players such as AngioDynamics, Inc. has enhanced its Oncology business with the addition of BioScentry technology. This step has been taken as a thoughtful and strategic acquisition, which would help the company in delivering economically favorable, clinically relevant and deliver safer solutions for the improvement of patient outcomes.

A recent study by Future Market Insights envisages that market for central venous catheter has been anticipated to expand at a steady 5.1% CAGR during 2016 to 2026. Inadequate quality check and high-costs with regards to catheters are key challenges limiting growth of market for central venous catheters, especially in the developing regions such as Middle East, Asia-Pacific and Africa. Non-tunneled central venous catheters is likely to hold the lion’s share in market for central venous catheters as it has been highly beneficial during emergency situations for blood withdrawal purposes. Hospitals contribute towards the maximum usage of central venous catheters owing to increased number of surgical care and quality facilities to its patients.

Polyurethanes are now being preferred over silicon for the production of central venous catheters, in light of the material’s relative compatibility and softness. However, multi-lumen catheters have taken the lead in terms of design, as it helps in reducing the frequency of catheter insertion, thereby enabling multiple drugs to get inserted with a single catheter.

North America is likely to dominate market for central venous catheters during the forecast period. The report says that central venous catheter market in the U.S. is the most profitable market in North America as the region has been witnessing increasing number of FDA approvals for the antimicrobial coated catheters. Asia-Pacific will display significant growth opportunities for market for central venous catheters in the forthcoming years on account of rising number of specialized clinics and hospitals in China and India. Rapidly increasing need for innovative medical technologies is expected to strengthen its position as healthcare hub in APEJ.

Key players and manufacturers in market for central venous catheters have been taking immense efforts in product launches with regards to antimicrobial coated catheters, due to increasing cases of infections thereby stimulating the production sales of the product across the globe. The U.S. FDA (Food and Drug Administration) has approved the antimicrobial coated central venous catheters for preventing bloodstream infections related to catheter.

Access Report with Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-949 

Latest technological innovations have resulted in the interventional surgeons, anesthesiologists and radiologists having access to the technologically improved central venous catheters. As a consequence, tip location devices, which helps in accurate and precise location of the catheter’s tip, are gaining increased momentum.. In addition, there have been innovations such as new catheter material compositions, which helps in improving user’s post and pre-catheterization. Antimicrobial coatings, which help in preventing infections and biocompatible materials such as polymer and silicone mixes that are substituting latex materials, are also witnessing high demand in order to reduce the intensity of pain during administration.

Dermatology Devices Market Revenue Predicted to Go Up by 2026

Dermatology devices market is a billion dollars market accounting for a substantial proportion of healthcare expenditure globally. In a new report titled “Dermatology Devices Market: Global Industry Analysis and Opportunity Assessment, 2016–2026” Future Market Insights offers a 10-year forecast for the global dermatology devices marketand provides insights on the drivers, restraints, opportunities, and trends likely to govern the global dermatology devices market during the forecast period (2016 – 2026). According to Future Market Insights analysis, the global dermatology devices market is expected to reach US$ 2,708.4 Mn in terms of revenue by 2016 end, witnessing a year-over-year growth of 6.2%.

A Sample of this Report is Available upon Request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1187

Factors such as rising prevalence of skin problems including acne leading to scars, increasing obesity, and growing aesthetic awareness among people are likely to contribute to the revenue growth of the global dermatology devices market over the forecast period. Economic factors such as growing healthcare expenditure, increasing disposable income per capita, and rising government support in developed economies are expected to boost the growth of the global dermatology devices market over the forecast period.

Segmentation highlights

The global dermatology devices market is segmented on the basis of Product Type (Lasers, RF Devices, Microdermabrasion Devices, Others); Application (Vascular Lesions, Tattoo Removal, Hair Removal, Wrinkle Removal, Scar Removal, Acne Removal, Others); and End User (Hospitals, Specialty Dermatology Clinics, Private Clinics).

• The Lasers product type segment is projected to dominate the global dermatology devices market in terms of value over the forecast period. This segment is anticipated to hold a market value share of 46.5% by the end of 2016
• The RF Devices product type segment is expected to be the second most lucrative segment in the global dermatology devices market
• The Vascular Lesions application segment is expected to account for 18.2% revenue share of the global dermatology devices market by 2016 end
• The Hair Removal application segment is expected to reach US$ 915.6 Mn by 2026 owing to increase in prevalence of polycystic ovarian syndrome in women
• The Speciality Dermatology Clinics end user segment is anticipated to reach a market valuation of US$ 2,005.3 Mn by 2026
• The Private Clinics end user segment is expected to account for 30.3% revenue share of the global dermatology devices market by 2016 end

Regional market projections

The global dermatology devices market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The demand for non-invasive cosmetic correction procedures has been significantly high in the U.S. market in the recent years, making North America the most lucrative market globally. In addition to North America, demand for non-invasive cosmetic procedures has been significantly growing in Western Europe and APEJ. Western Europe is expected to account for 20.3% revenue share of the global dermatology devices market by 2016 end.

Access Report with Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-1187

Vendor insights

The global dermatology devices market report profiles some of the leading companies operating in the global dermatology devices market such as Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis, Syneron Candela Ltd., Avita Medical Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Cutera, Lutronics Corporation, and Beijing Toplaser Technology Co. Ltd. Major market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Lumenis acquired Pollogen to strengthen and expand its aesthetic products portfolio. Similarly, in May 2016, Alma Lasers launched Accent Prime that combines ultrasound and unipolar radio frequency technologies to provide enhanced body contouring and skin tightening treatments.

Ophthalmic Lasers Market is Growing at Significant Rate, 2026

Increasing awareness and demand for non-invasive treatment coupled with the rising graph of ophthalmic diseases and disorders is the prime growth driver of the global ophthalmic lasers market. According to the latest estimates of the Glaucoma Research Foundation, an estimated 3 million Americans suffer from glaucoma, accounting for 9% to 12% of all cases of blindness and reflecting more than 120,000 cases. According to the World Health Organization, glaucoma is the second leading cause of blindness around the globe after cataract. The worldwide estimates put the total number of glaucoma cases at over 60 million. Thus a large and sustainable market is easily comprehendible, which is affirmed by the fact that glaucoma alone accounts for over 10 million visits to ophthalmologist each year.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1529 

According to a latest report by Future Market Insights (FMI), the global ophthalmic lasers market is projected to account for over US$ 697.1 Mn, in terms of value, by 2026 end. The report on the global ophthalmic lasers market further projects significant growth potential with average year-on-year growth rate pegged at 3.7% through 2026 at a significant CAGR of 4.8%.

The increasing risk factors such as ageing, diabetic retinopathy, severe nearsightedness are the demographic drivers of the global ophthalmic lasers market. These risk factors are responsible for the growing prevalence of glaucoma which currently is 2.65% in people above 40 years of age and has resulted in irreversible blindness in about 3 million people globally.

According to FMI, based on the disease type, the glaucoma segment accounted for over 42.1% revenue share in the overall ophthalmic lasers market in 2017. The glaucoma segment is expected to grow at an impressive 5.5% CAGR driving the market to greater heights. Diabetic retinopathy segment is expected to account for second large share in the global ophthalmic lasers market. According to the CDC, 4.2 million adults in the U.S. suffer from diabetic retinopathy.

The advancement in technology such as the development of advanced lasers with a wider spectrum and range of light emissions suitable for different types of conditions and diseases such as the Nd:YAG laser for acute angle closure glaucoma, and posterior capsular opacification after cataract surgery; frequency double-d green laser for diabetic retinopathy, macular oedema, retinopathy from vein or arterial occlusions, plateau iris syndrome and others are contributing to the growth of the market. Development of technology and frequency modulation have also resulted in smaller footprint in the surgery owing to time reduction exemplified by the femtosecond laser used in corneal and cataract surgery.

The restraints on the global ophthalmic lasers market are the concerns over the safety and effectiveness of laser therapy. Traditional cataract surgery is recognized as being safe and effective over laser surgery. Laser cataract surgery, is also not covered by most insurance plans, which coupled to greater costs associated with it hampers the growth of the global ophthalmic lasers market. The development of healthcare infrastructure and the advances in ophthalmic imaging coupled with the growing healthcare infrastructure is driving a large market. Growing per capita income and the growing penetration of health insurance is driving a large demand led growth of the global ophthalmic lasers market

Asia Pacific is expected to possess a large market equity than the developed regions such as North America and Europe owing to developing economy.  Further, the growing economies such as China and India are expected to play a major role in the growth of the Asia Pacific ophthalmic lasers market owing to their large population base. India, alone possess an estimated number of 12 million cases, accounting about one-fifth of the global burden of glaucoma. Increasing geriatric population and rising disposable income in Asia Pacific is expected to surge the demand for advanced ophthalmic lasers products.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-1529 

The report tracks some of the key companies operating in the ophthalmic lasers market, such as Ellex Medical PTY Ltd., NIDEK CO., LTD., Novartis AG, Lumenis Ltd., Topcon Corporation, Quantel SA, and IRIDEX Corporation, among others. Most of the companies have adopted product development as a strategy to gain maximum market share.

3D Printed Medical Devices Market Expecting Worldwide Growth by 2027

Future Market Insights presents pertinent insights and a revised forecast of the global 3D printed medical devices market in its published report titled ‘3D Printed Medical Devices Market”: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’. The global 3D printed medical devices market is expected to expand at a CAGR of 18.1% during the forecast period 2017–2027.  Increasing prevalence of chronic diseases and rising awareness regarding personal care are major factors that are driving the growth of the 3D printed medical devices market.

Increased Ability to Innovate Aids the Global 3D Printed Medical Devices Market

With increasing popularity of 3D printing, medical devices manufacturers are particularly focused on innovations. Substantial need for individualized yet economical medical solutions is met through 3D printing. Complex features of integration such as hard and soft areas, solid and porous structures, multi-material and multi-color, which seemed to be difficult by implementing conventional manufacturing techniques, is made simpler through 3D printing. Patient-specific implants are being manufactured based on CT and MRI scans provided by surgeons, which results in reduction of the overall surgical cost. This has increased the popularity of 3D printed medical devices all around the world.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1501 

Global 3D Printed Medical Devices Market: Segmentation and Forecast

The global 3D printed medical devices market is segmented based on application, technology, material type, end user and region. On the basis of application, the market has been segmented into orthopedic Implants, dental implants and cranio-maxillofacial implants. Orthopaedic implants application segment accounted for a higher revenue share in global 3D printing devices as compared to others in application segment. Orthopaedic implants segment in the application category of the global 3D printed medical devices market was estimated to be valued at nearly US$ 170 Mn in 2017 and is slated to reach a valuation of nearly US$ 970 Mn in 2027, exhibiting a CAGR of 19.2% during the period of assessment.

Based on the material type, 3D printed medical devices market is segmented into metals and alloys, biomaterial inks and plastics. The biomaterial inks segment was estimated to be valued at nearly US$ 65 Mn in 2017 and is anticipated to reach a valuation of nearly US$ 400 Mn in 2027, displaying a CAGR of 20% during the period of forecast.

Based on the end user, 3D printed medical devices market is segmented into hospitals, ambulatory surgical centres and diagnostic centres. Hospital end user segment accounts for higher demand for 3D printing devices as compared to other distribution channel segments such as ambulatory surgical centres and diagnostic centres, registering a CAGR of 18.7% over the forecast period.

Global 3D Printed Medical Devices Market: Regional Forecast

On the basis of region, the global 3D printed medical devices market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East and Africa. Revenues in Western Europe are expected to grow at a CAGR of 18.6%, whereas Eastern Europe is anticipated to grow at 15.5% over the forecast period. The Western Europe 3D printed medical devices market was estimated to be valued at nearly US$ 65 Mn in 2017 and is slated to reach a value of nearly US$ 360 Mn in 2027. The Eastern Europe 3D printed medical devices market was estimated to be valued at nearly US$ 40 Mn in 2017 and is anticipated to reach a value of nearly US$ 160 Mn in 2027.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-1501 

Global 3D Printed Medical Devices Market: Competitive Landscape

Some of the players in the global 3D printed medical devices market include 3D Systems, Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K. and Formlabs, Inc. among others. Key players are focusing on strengthening their position by establishing new facilities in North America region. Moreover, companies are targeting Asia-Pacific region and Europe by distribution agreements with local players. In order to increase their revenue, major players in the North America region are entering into agreements with hospitals and academic institutes.

North America Vision Care Market is Expecting Worldwide Growth by 2026

Future Market Insights delivers key insights on the North America vision care market in a new publication titled “Vision Care Market: North America Industry Analysis and Opportunity Assessment, 2016 – 2026”. Vision care is a billion dollar market accounting for a substantial proportion of worldwide healthcare expenditure. In terms of revenue, the North America vision care market is expected to reach US$ 39.7 Bn in 2016, witnessing a year-on-year growth of 7.2%. In this report, Future Market Insights analyses the factors and trends impacting the growth and performance of the North America vision care market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-na-2018 

According to Future Market Insights analysts, factors such as rising prevalence of eye diseases leading to eye surgery procedures, an increasing geriatric population, and the introduction of new and advanced vision care products are major factors expected to fuel the revenue growth of the North America vision care market over the forecast period. Economic factors such as growing healthcare expenditure, increasing disposable income per capita, rising government support in developed economies, and favourable reimbursement policies are also expected to boost the growth of the North America vision care market over the forecast period. However, rise in the costs of eye surgery and treatment and a risk of infection and vision loss may hinder the growth of the North America vision care market over the forecast period.

Sales of vision care services has remained quite healthy in the U.S. market in the recent years, making North America the most lucrative market globally. The North America vision care market revenue was accounted to be US$ 37.1 Bn in 2015, with the U.S. accounting for majority of revenue share.

Segmentation highlights

The North America vision care market can be broadly classified into six product segments – Rx lenses, frames, non Rx sunglasses, contact lenses, readers, and contact lens solutions – each with different applications.

• By product, Rx lenses accounted for higher revenue share in North America as compared to other product segments
• The Frames product type segment accounted for the second largest revenue share followed by the contact lenses product segment in 2015. The contact lenses segment is expected to register the highest CAGR of 12.4% during the forecast period
• By distribution channel, the retail segment accounted for a higher revenue share in the North America vision care market as compared to other distribution channels
• The Retail segment is expected to reach a market valuation of US$ 60.6 Bn by 2026, reflecting a CAGR of 9.8% over the forecast period
• The E-commerce segment is also expanding at a higher rate in the overall North America vision care market. This segment is expected to reach US$ 18.9 Bn by the end of 2026, registering a CAGR of 3.8% over the forecast period

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-na-2018 

Vendor insights

Key players in the North America vision care market include Johnson & Johnson Vision Care Inc., Valeant Pharmaceuticals International Inc., Novartis AG, The Cooper Companies Inc., SynergEyes Inc., Luxottica, Essilor International, and ZEISS International. Major market players are adopting different strategies such as partnerships and acquisitions to maintain and expand their market share. Recently in January 2016, Valeant pharmaceuticals expanded its specialty lens business with the addition of Alden Optical Laboratories Inc. In 2016, Essilor International reinforced its expansion with independent eye care professionals in the U.S with the acquisition of Vision Source.

Prosthetic Heart Valve Market to Reflect Significant Growth Pace by 2026

The global prosthetic heart valve market was valued at US$ 5,650 Mn in 2015 and is estimated to be valued at US$ 6,304 Mn by 2016, projecting a Y-o-Y growth of 11.6%. A new report titled “Prosthetic Heart Valve Market: Global Industry Analysis and Opportunity Assessment, 2016–2026,” published by Future Market Insights analyses the factors and trends defining the growth and performance of the global prosthetic heart valve market over a 10-year forecast period (2016 – 2026).

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

A Sample of this Report is Available upon Request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-666

Segmentation highlights

The global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).

• The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
• The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional market projections

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions. The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%. Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Vendor insights

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. Leading market players are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Access Report with Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-666

Key competitors covered in terms of prosthetic heart valve market are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNovaPLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc. Key strategies adopted by most of the major players in the global prosthetic heart valve market include: product approvals and commercialisation, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.